Swab and Viral Transport Medium Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2022-2030
The global swab and viral transport medium market is estimated to exhibit a CAGR of 1.2 % over the forecast period 2020-2030, according to a new research by Future Market Insights (FMI).
An upswing in the sales of critical equipment with respect
to collection and transportation of samples is currently underway. This has
escalated the production of swab and viral transport medium, thereby driving
the market.
To detect the viral RNA in human body; nasopharyngeal swab
and deep nasal swab techniques are being used. The overall market is primarily
driven by increased rate of flu in various regions. As per CDC, 2019-20 season
has witnessed close to 20 Mn cases of influenza in the U.S. with 280,000
hospitalizations as on Feb 15, 2020.
Get the Sample here: https://www.futuremarketinsights.com/reports/sample/rep-gb-11195
At the same time, efforts taken by respective governments to
increase awareness about flu, coupled with initiatives undertaken by World
Health Organization (WHO), Global Alliance for Vaccines and Immunization
(GAVI), The Pan American Health Organization (PAHO), etc. are expected to drive
the market.
“Expanded Program on Immunization” is one the initiatives
taken by PAHO at the pan American level. In Jan 2020, GAVI, at the behest of
MSF (Doctors without Borders) bulk brought cheaper pneumococcal vaccine for
around 55 Mn children. The initiatives mentioned above would be taken up in the
forecast period as well. That will certainly ask for more swab and viral
transformation motion to be in place.
New product launches and approvals along with increasing
demand due to current situation are driving growth of the global swab and viral
transport medium market” says the FMI Analyst
Key Takeaways from Swab and Viral Transport Medium Market
Study
- The
global market for swab and viral transport medium is showing sharp
increment in the year 2020 due to outbreak of Covid-19 with increase in
demand for pool of patients going for certain diagnostic tests.
- Based
on symptoms, influenza, coronavirus, and hanta virus are expected to
collectively hold more than 50% of revenue in the year 2020.
- Among
all end users, diagnostic laboratories are anticipated to witness a CAGR
of 1.6% over the forecast period.
- North
America and Europe collectively accounted for more than 70% of revenue
share in 2019 while Asia Pacific is expected to show greater growth
potential over the forecast period.
- Asia
Pacific is expected to upturn the swab and viral transport medium market
in the years to come with local players going for in-house swabs
New Product Launches: Key Strategic Focus Area of Swab
and Viral Transport Medium Market Players
New product launches/approvals and governments’ support are
raising the bar for competition amongst market players. Numerous organizations
are focusing on new product launches for diagnostic test especially for
coronavirus and influenza. For Instance, DiaSorin, a prominent manufacturer of
swabs specifies NP swabs in 3 ml of Copan Universal Transport Media (UTM) or BD
Viral Transport Media. In 2019, MWE launched ∑-VCM™ transport device, to enable
the collection, transport and preservation of viruses.
The other players included as a part of market study include
McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company,
Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc.,
VIRCELL S.L., Deltalab, and Medical Wire & Equipment (MWE).
About the Report
Future Market Insights brings the comprehensive research
report at global, regional, and country levels and provides an analysis of the
latest industry trends in each of the sub-segments from 2015 to 2030. The
global swab and viral transport medium market covers every aspect of the market
and presents a complete market intelligence approach to the reader. The
study provides compelling insights on swab and viral transport medium market on
the basis of product type (nasopharyngeal swab, deep nasal swabs, combined
nasal & throat swabs, culture swabs and vaginal swabs). By indication, the
market covers influenza, respiratory syncytial virus, mumps virus, adenovirus,
rhinovirus, herpes simplex virus, varicella-zoster virus, and others. End user
covers (diagnostic laboratories, hospitals & ambulatory surgical centers
and specialty clinics and others) across seven major regions.
About Healthcare Division at Future Market Insights
Comments
Post a Comment